The table below shows HUTCHMED (China) Ltd's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$64.66M
$497.00K
$219.26M
-$268.60M
-$204.22M
-$62.07M
Capital expenditure
$14.15M
$17.93M
$32.61M
$36.66M
$16.40M
$7.95M
Investing cash flow
-$29.41M
-$96.06M
-$291.14M
$296.59M
-$306.32M
-$125.44M
Dividends paid
-
-
-
-
-
HCM operating cash flow (10-K history)
HUTCHMED (China) Ltd reported operating cash flow of -$64.66M for fiscal year 2025. That is down 13109.5% from $497.00K in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$9.57M (FY 2016) to -$64.66M. Figures come from the company's audited annual reports as filed with the SEC.
